Elite Pharmaceuticals Inc (ELTP)
0.6168
0.00 (0.00%)
USD |
OTCM |
Nov 22, 15:59
Elite Pharmaceuticals Total Assets (Quarterly): 88.20M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 88.20M |
| June 30, 2024 | 87.85M |
| March 31, 2024 | 83.65M |
| December 31, 2023 | 74.70M |
| September 30, 2023 | 70.72M |
| June 30, 2023 | 46.50M |
| March 31, 2023 | 40.90M |
| December 31, 2022 | 52.72M |
| September 30, 2022 | 50.34M |
| June 30, 2022 | 48.11M |
| March 31, 2022 | 35.15M |
| December 31, 2021 | 31.95M |
| September 30, 2021 | 30.62M |
| June 30, 2021 | 29.99M |
| March 31, 2021 | 26.19M |
| December 31, 2020 | 28.67M |
| September 30, 2020 | 27.61M |
| June 30, 2020 | 27.82M |
| March 31, 2020 | 24.96M |
| December 31, 2019 | 24.09M |
| September 30, 2019 | 23.53M |
| June 30, 2019 | 24.28M |
| March 31, 2019 | 24.40M |
| December 31, 2018 | 26.38M |
| September 30, 2018 | 27.32M |
| Date | Value |
|---|---|
| June 30, 2018 | 28.50M |
| March 31, 2018 | 30.88M |
| December 31, 2017 | 32.07M |
| September 30, 2017 | 32.01M |
| June 30, 2017 | 33.89M |
| March 31, 2017 | 34.31M |
| December 31, 2016 | 36.20M |
| September 30, 2016 | 34.87M |
| June 30, 2016 | 33.06M |
| March 31, 2016 | 31.67M |
| December 31, 2015 | 27.13M |
| September 30, 2015 | 28.70M |
| June 30, 2015 | 29.91M |
| March 31, 2015 | 25.92M |
| December 31, 2014 | 25.70M |
| September 30, 2014 | 23.89M |
| June 30, 2014 | 23.97M |
| March 31, 2014 | 24.32M |
| December 31, 2013 | 18.28M |
| September 30, 2013 | 17.41M |
| June 30, 2013 | 10.39M |
| March 31, 2013 | 11.13M |
| December 31, 2012 | 10.37M |
| September 30, 2012 | 10.07M |
| June 30, 2012 | 10.19M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
24.09M
Minimum
Dec 2019
88.20M
Maximum
Sep 2024
46.54M
Average
38.02M
Median
Total Assets (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 6.851B |
| BioCardia Inc | 6.267M |
| Zevra Therapeutics Inc | 191.55M |
| Verrica Pharmaceuticals Inc | 32.93M |
| Terns Pharmaceuticals Inc | 378.23M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 40.93M |
| Shareholders Equity (Quarterly) | 47.27M |
| Debt to Equity Ratio | 0.1575 |
| Current Ratio | 3.524 |
| Net Debt Paydown Yield | 0.02% |